In March 2026, China’s National Medical Products Administration approved NEO, a brain-computer interface developed by Shanghai-based startup Neuracle Technology with researchers at Tsinghua University, for commercial use in patients with paralysis caused by spinal cord injuries. It is the first invasive BCI to clear a national regulator for use beyond clinical trials anywhere in the [...] The post China approved the world’s first commercial brain implant before Neuralink — and the key difference